| Latest Forum Topics / SingMedical |
|
|
The Next Medical Stock to watch
|
|||||
|
idunnoleh
Member |
21-Feb-2019 11:12
|
||||
|
x 0
x 0 Alert Admin |
I agree with you that retail/minority shareholders like me are losing out from a corp gov standpoint. if they want to acquire more shares, why not open it to everyone? Sadly, this stock is severely undervalued and illiquid. Even if its valued at 0.60+ cents, the market is not moving close to that.  But I believe in its intrinsic value and in the long term, so I will continue to hold until the market sees its potential or taking it private. Clearly the financials are proving that this stock is a hidden gem.  
|
||||
| Useful To Me Not Useful To Me | |||||
|
alexchew
Master |
21-Feb-2019 10:36
|
||||
|
x 0
x 0 Alert Admin |
to me, obviously, mgt sold out minority.. they offloaded at 0.60+, and you guys are stuck at 0.4+... Why can' t a private placement of new shares be done to make this deal beneficial to all instead of the mgt only exercise? Company did not reap any benefits out of this deal. 
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
BillionX
Senior |
21-Feb-2019 10:33
|
||||
|
x 0
x 0 Alert Admin |
CHA now owns more than 24% of SM. Will the former make a formal acquistion of the latter and take it private? Obviouslt CHA sees value in an undervalued stock. | ||||
| Useful To Me Not Useful To Me | |||||
|
calvinlooi
Senior |
21-Feb-2019 08:48
|
||||
|
x 0
x 0 Alert Admin |
Lai, $0.60 today. | ||||
| Useful To Me Not Useful To Me | |||||
|
calvinlooi
Senior |
20-Feb-2019 18:19
|
||||
|
x 0
x 0 Alert Admin |
Any view on the convertible loan? | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
NickRevell
Member |
13-Feb-2019 16:17
|
||||
|
x 0
x 0 Alert Admin |
Dividend coming? | ||||
| Useful To Me Not Useful To Me | |||||
|
calvinlooi
Senior |
20-Dec-2018 19:22
|
||||
|
x 0
x 0 Alert Admin |
Buy now and wait for next result. | ||||
| Useful To Me Not Useful To Me | |||||
|
calvinlooi
Senior |
12-Dec-2018 12:41
|
||||
|
x 0
x 0 Alert Admin |
Impossible to declare dividend for current, as the company level is still accumulated loss. Buy now is for future value. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
BillionX
Senior |
12-Dec-2018 11:53
|
||||
|
x 1
x 0 Alert Admin |
Let?s hope the management declares a dividend. Good fundamentals but stingy on sharing the fruits with minority shareholders is holding down the share price . | ||||
| Useful To Me Not Useful To Me | |||||
|
calvinlooi
Senior |
11-Dec-2018 18:57
|
||||
|
x 0
x 0 Alert Admin |
The company still got 4.4m for m& a from previous right issue proceed. Good news in coming? |
||||
| Useful To Me Not Useful To Me | |||||
|
sfnssie
Member |
10-Dec-2018 22:41
|
||||
|
x 0
x 0 Alert Admin |
SingMedical (5OT) has been showing support at 0.38 and resistance at 0.429. Technical indicators are looking bullish, according to s g x . s t o x l i n e. 
|
||||
| Useful To Me Not Useful To Me | |||||
|
calvinlooi
Senior |
10-Dec-2018 19:13
|
||||
|
x 0
x 0 Alert Admin |
Slow and positive movement  | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
calvinlooi
Senior |
06-Dec-2018 17:19
|
||||
|
x 0
x 0 Alert Admin |
You mean it will not go up to more than 45 cents? I  see some volume movements, let' s see how.   |
||||
| Useful To Me Not Useful To Me | |||||
|
hotelgrand
Master |
06-Dec-2018 15:35
|
||||
|
x 0
x 0 Alert Admin |
Consistent tradung below rights price 45cts..gonna | ||||
| Useful To Me Not Useful To Me | |||||
|
easywin
Supreme |
06-Dec-2018 14:26
|
||||
|
x 0
x 0 Alert Admin |
SGX got many counters   undervalued due to market sentiment is bad plus BBs did not help to push up.
|
||||
| Useful To Me Not Useful To Me | |||||
|
calvinlooi
Senior |
06-Dec-2018 13:41
|
||||
|
x 0
x 0 Alert Admin |
SingM has been in my watchlist for long time, i did not vest it until now is because the volume was too low, but there are some activities recently. The share price was low since the right issue last year,  the proceed is used for takeover purposes. Profit have been growing very fast for two years, to me, not much people noticed the shares and is of undervalued. Feel free to discuss your view. |
||||
| Useful To Me Not Useful To Me | |||||
|
jamesbywater
Veteran |
06-Nov-2018 19:28
Yells: "Be greedy when others are fearful. " |
||||
|
x 1
x 0 Alert Admin |
SMG' s 9M2018 net profit of S$10.0 million makes up 76% of analyst consensus estimates for FY18 as the Group continues to deliver earnings quality. Furthermore, SMG is trading at 12.6x FY18 PE versus healthcare peers who are trading at 26.8x FY18 PE, a steep discount to peers. While charting growth across the region in markets such as Vietnam and Indonesia, the Group is also exploring implementing a formal dividend policy in FY2019. Backed by a strong management team, structural factors such as an ageing population and increasing lifestyle diseases should provide additional tailwinds. Insulated from the trade war, it might be time to look at this once multi-bagger counter once again. | ||||
| Useful To Me Not Useful To Me | |||||
|
NL0261
Senior |
27-Jul-2018 09:38
|
||||
|
x 0
x 0 Alert Admin |
Oh yes, all are sleeping except the 3 banks n tats why try runs like lambo .....all the funds n retirees r in there
|
||||
| Useful To Me Not Useful To Me | |||||
|
Myopinion
Senior |
27-Jul-2018 09:31
|
||||
|
x 0
x 0 Alert Admin |
Very sleepy counter.... | ||||
| Useful To Me Not Useful To Me | |||||
|
n3wbie
Elite |
26-Jul-2018 00:13
|
||||
|
x 0
x 0 Alert Admin |
With trade wars and geopolitical tensions cluttering headlines, would it be worthwhile to consider healthcare sector to be insulated from all these market noise? SMG in particular is the largest private healthcare specialist in Singapore with footprint in fast-growing Vietnamese market. Seems plausible that the best practices in our domestic market can be replicated and exported overseas, leveraging on Singapore' s brand and reputation in the healthcare sector. Quantitatively, valuations are compelling and there is a clear valuation gap with industry peers. SMG is presently trading at c15x FY18 PE while industry peers have a median & mean FY18 PE multiples of c29x. Yes, the number is skewed because of asset-based healthcare players such as RMG, HMI and IHH which command PE multiples of 22 - 44x FY18 PE. More relevant peers such as SOG, TalkMed, HC Surgical and maybe to a lesser extent, Q& M however also command FY18 PE multiples of 20-32x. Point in case - SMG commands the lowest PE multiple among its peers. The market is probably pampered by its triple digit growth over the years, led by inorganic growth. It is quite a shame that the integration and synergies this year, as outlined in its recently published strategic review were blindsided by most investors. Taking a quick slice at the financial numbers, FY17 reported $8.5m PATMI and analysts are forecasting c$13m for FY18 so that is 53% yoy increase, translating to a PEG of 0.28 at present valuation. The growth thesis sounds compelling enough, at least academically, and subject to execution risks as with any business. Lastly,    all the key management, including Korean healthcare group, CHA subscribed to the rights at 1:20 at 48c. Today' s closing of 42.5c is a further 11% discount from rights issue price - whether or not it is justified is obviously debatable. |
||||
| Useful To Me Not Useful To Me | |||||


